Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B1 | P14061 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.56 |
| ▸ | RXRA | P19793 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Erybraedin C SCHEMBL29572548 | 0.82 | PTPN1 (0.77) | HSD17B1PTPN1 | |
| Phaseollidin SCHEMBL1545850 | 0.81 | PTPN1 (0.77) | HSD17B1PTPN1 | |
| Phaseollidin SCHEMBL29349654 | 0.81 | PTPN1 (0.77) | HSD17B1PTPN1 | |
| Erybraedin A SCHEMBL29572007 | 0.78 | PTPN1 (0.76) | HSD17B1PTPN1 | |
| SCHEMBL29705706 | 0.73 | PTPN1 (0.65) | HSD17B1PTPN1 | |
| SCHEMBL23483682 | 0.72 | HSD17B1 (1.00) | HSD17B1PTPN1 | |
| SCHEMBL22948232 | 0.72 | HSD17B1 (1.00) | HSD17B1PTPN1 | |
| SCHEMBL30260469 | 0.72 | HSD17B1 (1.00) | HSD17B1PTPN1 | |
| SCHEMBL31237827 | 0.72 | PTPN1 (0.73) | HSD17B1PTPN1 | |
| Erybreadin B SCHEMBL31237953 | 0.72 | PTPN1 (1.00) | HSD17B1PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4662319-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | Integrate Bioscience LLC (US) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024168301-A2 | PERSONALIZED CRISPR PROFILING FOR CANCER | FUNCTION ONCOLOGY, INC. (US) | 2024-08-15 | — | — | WO | disclosed |